4
Changes in Ownership
Apimeds Pharmaceuticals US, Inc. Filed Acc 0001474506-25-000099
Chief Executive Officer acquired 750,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Emerson Erik C. Chief Executive Officer | 2025-05-16 | Grant or award | +750,000 | 750,000 | D | ||
| Derivatives | |||||||
| Emerson Erik C. Chief Executive Officer | 2025-05-16 | Grant or award · Stock option (right to buy) | +347,279 | 347,279 | D | ||
Loading xslF345X05/primary_doc.xml…